Published in

Elsevier, Lancet Gastroenterology and Hepatology, 2(8), p. 145-156, 2023

DOI: 10.1016/s2468-1253(22)00389-2

Links

Tools

Export citation

Search in Google Scholar

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

Journal article published in 2023 by Zhigang Liu ORCID, Kaixing Le, Xin Zhou, James L. Alexander, Simeng Lin, Claire Bewshea, Neil Chanchlani, Rachel Nice, Timothy J. McDonald, Christopher A. Lamb, Shaji Sebastian, Klaartje Kok, Charlie W. Lees, Ailsa L. Hart, Richard C. Pollok and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO